A combination of doxycycline and ribavirin alleviated chikungunya infection

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Rothan, Hussin A ^a   Bahrani, Hirbod ^a   Mohamed, Zulqarnain ^b   Teoh, Teow Chong ^b   Shankar, Esaki M ^a   Rahman, Noorsaadah A ^a   Yusof, Rohana ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; CYSTEINE PROTEINASE; DOXYCYCLINE; GLYCOPROTEIN E2; RIBAVIRIN; ANTIVIRUS AGENT;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; CHIKUNGUNYA; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG POTENCY; DRUG SCREENING; DRUG STRUCTURE; EC50; IN VITRO STUDY; IN VIVO STUDY; MOLECULAR DOCKING; MOUSE; NONHUMAN; TOXICITY TESTING; VERO CELL LINE; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS INACTIVATION; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS PARTICLE; VIRUS REPLICATION; ANIMAL; CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; CHLOROCEBUS AETHIOPS; COMBINATION DRUG THERAPY; DRUG EFFECTS; INSTITUTE FOR CANCER RESEARCH MOUSE; PRECLINICAL STUDY; VIROLOGY;

ANIMALIA; CHIKUNGUNYA VIRUS; MUS;

ANIMALS; ANTIVIRAL AGENTS; CERCOPITHECUS AETHIOPS; CHIKUNGUNYA FEVER; CHIKUNGUNYA VIRUS; DOXYCYCLINE; DRUG EVALUATION, PRECLINICAL; DRUG THERAPY, COMBINATION; MICE, INBRED ICR; RIBAVIRIN; VERO CELLS; VIRUS ATTACHMENT; VIRUS REPLICATION;

EID: 84929378845     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126360     Document Type: Article

References (45)

1. Pialoux G, Gauzere BA, Jaureguiberry S, Strobel M. Chikungunya, an epidemic arbovirosis. Lancet Infect Dis 2007: 7: 319-327. PMID: 17448935
2. Powers AM, Logue CH. Changing patterns of Chikungunya virus: re-emergence of a zoonotic arbovirus. J Gen Virol 2007: 88: 2363-2377. PMID: 17698645
3. Staples JE, Breiman RF, Powers AM. Chikungunya fever: an epidemiological review of a re-emerging infectious disease. Clin Infect Dis 2009; 15 (49): 942e8. doi: 10.1086/605496 PMID: 19663604
4. Tsetsarkin KA, Vanlandingham DL, McGee CE, Higgs S. A single mutationin chikungunya virus affects vector specificity and epidemic potential. PLoS Pathog 2007; 3(12): 1895-1906.
5. Caminade C, Medlock JM, Ducheyne E, McIntyre KM, Leach S, Baylis M, et al. Suitability of European climate for the Asian tiger mosquito Aedes albopictus: recent trends and future scenarios. J R Soc 2012; 9(75): 2708-2717. doi: 10.1098/rsif.2012.0138 PMID: 22535696
6. Bajak A. US assesses virus of the Caribbean Nat. 2014; 512: 124-125. doi: 10.1038/512124a PMID: 25119220
7. Braschi I, Blasioli S, Gigli L, Gessa CE, Alberti A, Martucci A. Removal of sulfonamide antibiotics from water: evidence of adsorption into an organophilic zeolite Y by its structural modifications. J. Hazard. Mater 2010; 178: 218-225. doi: 10.1016/j.jhazmat.2010.01.066 PMID: 20133061
8. Ji LL, Liu FL, Xu ZY, Zheng SR, Zhu DQ. Adsorption of pharmaceutical antibiotics on template-synthesized ordered micro- and mesoporous carbons, Environ. Sci. Technol 2010; 44: 3116-3122. doi: 10.1021/es903716s PMID: 20201519
9. Homem V, Santos L. Degradation and removal methods of antibiotics from aqueous matrices. J. Environ. Manage 2011; 92: 2304-2347. doi: 10.1016/j.jenvman.2011.05.023 PMID: 21680081
10. Chao Y, Zhu W, Wu X, Hou F, Xun S, Wu P, et al. Application of graphene-like layered molybdenum disulfide and its excellent adsorption behaviour for Doxycycline antibiotic. Chem Eng J 2011; 243: 60-67.
11. Zhu J, Liu S, Liu Z, Li Y, Tian J, Hu X. A highly sensitive and selective assay of Doxycycline by dual wavelength overlapping resonance Rayleigh scattering. SPECTROCHIM ACTA A 2014; 124: 237-242. doi: 10.1016/j.saa.2013.12.114 PMID: 24486868
12. Polat KY, Tosun MS, Ertekin V, Aydinli B, Emre S. Brucella infection with pancytopenia after pediatric liver transplantation. Transpl Infect Dis 2012; 14: 326-329. doi: 10.1111/j.1399-3062.2011.00709.x PMID: 22260451
13. Waltera MS, Franka MJ, Satué M, Monjo M, Ronold HJ, Lyngstadaas SP, et al. Bioactive implant surface with electrochemically bound Doxycycline promotes bone formation markers in vitro and in vivo. Dent mater 2014; 30: 200-214. doi: 10.1016/j.dental.2013.11.006 PMID: 24377939
14. Drugs.com, Doxycycline, http://www.drugs.com/pro/doxycycline.html
15. Macdougall C, Chambers HF. Protein synthesis inhibitors and miscellaneous antibacterial agents. In: Brunton LL, Chabner AB, Knollmann CB, eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. 12th ed. New York, NY: McGraw-Hill; 2011; 1537-1538.
16. Kirchner JT, Hemmert D. Sexually transmitted diseases in women. Chlamydia trachomatis and herpes simplex infections. Postgrad Med 2000; 107(55-58): 55-61. PMID: 10887450
17. Ng HH, Narasaraju T, Phoon MC, Sim MK, Seet JE, Chow VT. Doxycycline treatment attenuates acute lung injury in mice infected with virulent influenza H3N2 virus: Involvement of matrix metalloproteinases. Exp Mol Pathol 2012; 92: 287-295. doi: 10.1016/j.yexmp.2012.03.003 PMID: 22421441
18. Quispe-Laime AM, Bracco JD, Barberio PA, Campagne CG, Rolfo VE, Umberger R, et al. H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment. J Intensive Care Med 2010; 36: 33-41.
19. Sturtz FG. Antimurine retroviral effect of Doxycycline. Methods Find Exp Clin Pharmacol 1998; 20: 643-647. PMID: 9922979
20. Yang JM, Chen YF, Tu YY, Yen KR, Yang YL. Combinatorial computational approaches to identify tetracycline derivatives as flavivirus inhibitors. PLoS One 2007; 2: e428. PMID: 17502914
21. Rothan HA, Mohamed Z, Paydar M, Rahman NA, Yusof R. Inhibitory effect of Doxycycline against dengue virus replication in vitro. Arch Virol 2013; doi: 10.1007/s00705-013-1880-7
22. Trott AO, Olson J. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization and multithreading, J Comput Chem 2010; 31: 455-461. doi: 10.1002/jcc.21334 PMID: 19499576
23. Michel FS. Python A programming language for software integration and development. J Mol Graphics Mod 1999; 17: 57-61. PMID: 10660911
24. Wyde PR, Wilson SZ, Gilbert BE, Smith RH. Protection of mice from lethal influenza virus infection with high dose-short duration RIBA aerosol. Antimicrob Agents Chemother 1986; 30: 942-944. PMID: 3813516
25. Rowe T, Banner D, Farooqui A, Ng DC, Kelvin AA, Rubino S, et al. In vivo RIBA activity against severe pandemic H1N1 influenza A/Mexico/4108/2009. J Gen Virol 2010; 91: 2898-2906. doi: 10.1099/vir.0.024323-0 PMID: 20797971
26. Tremblay P, Meiner Z, Galou M, Heinrich C, Petromilli C, Lisse T, et al. Doxycycline control of prion protein transgene expression modulates prion disease in mice. Proc Natl Acad Sci U S A 1998; 13: 12580-12585.
27. Parashar D, Paingankar MS, Kumar S, Gokhale MD, Sudeep AB, Shinde SB, et al. Administration of E2 and NS1 siRNAs Inhibit Chikungunya Virus Replication In Vitro and Protects Mice Infected with the Virus. PLoS Negl Trop Dis 2013; 7: e2405. doi: 10.1371/journal.pntd.0002405 PMID: 24040429
28. Panigrahi R, Chandra PK, Ferraris P, Kurt R, Song K, Garry RF, et al. Persistent HCV infection impairs ribavirin antiviral activity through clathrin-mediated trafficking of equilibrative nucleoside transporter 1. J Virol 2014; 22: VI.02492-14. doi: 10.1186/1687-9856-2014-22 PMID: 25435886
29. Fuster D, Huertas JA, Gomez G, Sola R, Gonzalez Garcia J, Vilaró J, et al. Baseline factors associated with haematological toxicity that leads to a dosage reduction of pegylated interferon-alpha2a and ribavirin in HIV- and HCV-coinfected patients on HCV antiviral therapy. Antivir Ther 2005; 10: 841-847. PMID: 16312180
30. Bizollon T, Adham M, Pradat P, Chevallier M, Ducerf C, Baulieux J, et al. Triple antiviral therapy with amantadine for IFN-ribavirin nonresponders with recurrent posttransplantation hepatitis C. Transplantation 2005; 79: 325-329. PMID: 15699763
31. Lawitz E, Rodriguez-Torres M, Muir AJ, Kieffer TL, McNair L, Khunvichai A, et al. Antiviral effects and safety of telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in hepatitis C patients. J Hepatol 2008; 49: 163-169. doi: 10.1016/j.jhep.2008.03.027 PMID: 18486984
32. Jeulin H, Grancher N, Kedzierewicz F, Finance C, Le Faou AE, Venard V, et al. In vivo antiviral activity of ribavirin/alpha-cyclodextrin complex: evaluation on experimental measles virus encephalitis in mice. Int J Pharm 2008; 357: 148-153. doi: 10.1016/j.ijpharm.2008.01.043 PMID: 18329830
33. Sebastian L, Desai A, Yogeeswari P, Sriram D, Madhusudana SN, Ravi V, et al. Combination of N-methylisatin-beta-thiosemicarbazone derivative (SCH16) with ribavirin and mycophenolic acid potentiates the antiviral activity of SCH16 against Japanese encephalitis virus in vitro. Lett Appl Microbiol 2012; 55: 234-239. doi: 10.1111/j.1472-765X.2012.03282.x PMID: 22738253
34. Darr S, Madisch I, Heim A. Antiviral activity of cidofovir and ribavirin against the new human adenovirus subtype 14a that is associated with severe pneumonia. Clin Infect Dis 2008; 47: 731-732. doi: 10.1086/590970 PMID: 18680401
35. Rothan HA, Buckle MJ, Ammar YA, Paydar M, Shatrah O, Noorsaadah AR, et al. Study the antiviral activity of some derivatives of tetracycline and non-steroid anti-inflammatory drugs towards dengue virus. Trop Biomed 2013; 30(4): 681-690. PMID: 24522138
36. Crotty S, Maag D, Jamie JA, Zhong W, Johnson YN, Hong Z, et al. The broad-spectrum antiviral ribonucleoside RIBA is an RNA virus mutagen. Nat Med 2000; 6: 1375-1379. PMID: 11100123
37. Pastorino BAM, Peyrefitte CN, Almeras L, Grandadam M, Rolland D, Tolou HJ, et al. Expression and biochemical characterization of nsP2 cysteine protease of Chikungunya virus. Virus Res 2008; 13: 293-298
38. Asnet MJ, Paramasivan R, Tyagi BK, Surender M, Shenbagarathai R. Identification of structural motifs in the E2 glycoprotein of Chikungunya involved in virus-host interaction. Journal of Biomol Struct Dyn 2013; 31: 1077-1085. doi: 10.1080/07391102.2012.721496 PMID: 23025271
39. Morrison TE, Oko L, Montgomery SA, Whitmore AC, Lotstein AR, Gunn BM, et al. A mouse model of chikungunya virus-induced musculoskeletal inflammatory disease: evidence of arthritis, tenosynovitis, myositis, and persistence. Am J Pathol 2011; 178(1):32-40. doi: 10.1016/j.ajpath.2010.11.018 PMID: 21224040
40. Poo YS, Nakaya H, Gardner J, Larcher T, Schroder WA, Le TT, et al. CCR2 deficiency promotes exacerbated chronic erosive neutrophil-dominated chikungunya virus arthritis. J Virol. 2014; 88(12):6862-72. doi: 10.1128/JVI.03364-13 PMID: 24696480
41. Yao HW, Ling P, Chen SH, Tung YY, Chen SH. Factors affecting herpes simplex virus reactivation from the explanted mouse brain. Virology. 2012; 10
42. Virology. 433(1):116-23. doi: 10.1016/j.virol.2012.07.018 PMID: 22884293.
43. Labadie K, Larcher T, Joubert C, Mannioui A, Delache B, Brochard P, et al. Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages. J Clin Invest 2010; 120: 894-906 doi: 10.1172/JCI40104 PMID: 20179353
44. Skulason S, Holbrook WP, Thormar H, Gunnarsson GB, Kristmundsdottir T. A study of the clinical activity of a gel combining monocaprin and Doxycycline: a novel treatment for herpes labialis. J Oral Pathol Med 2012; 41:61-67. doi: 10.1111/j.1600-0714.2011.01037.x PMID: 21535163
45. Manning MW, Cassis LA, Daugherty A. Differential effects of Doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 2003; 23: 483-488. PMID: 12615694